1576 related articles for article (PubMed ID: 17241267)
21. Glycosylation of microtubule-associated protein tau: an abnormal posttranslational modification in Alzheimer's disease.
Wang JZ; Grundke-Iqbal I; Iqbal K
Nat Med; 1996 Aug; 2(8):871-5. PubMed ID: 8705855
[TBL] [Abstract][Full Text] [Related]
22. Mechanisms of tau-induced neurodegeneration.
Iqbal K; Liu F; Gong CX; Alonso Adel C; Grundke-Iqbal I
Acta Neuropathol; 2009 Jul; 118(1):53-69. PubMed ID: 19184068
[TBL] [Abstract][Full Text] [Related]
23. The active form of glycogen synthase kinase-3beta is associated with granulovacuolar degeneration in neurons in Alzheimer's disease.
Leroy K; Boutajangout A; Authelet M; Woodgett JR; Anderton BH; Brion JP
Acta Neuropathol; 2002 Feb; 103(2):91-9. PubMed ID: 11810173
[TBL] [Abstract][Full Text] [Related]
24. Molecular pathology of Alzheimer neurofibrillary degeneration.
Iqbal K; Alonso A; Gong C; Khatoon S; Kudo T; Singh T; Grundke-Iqbal I
Acta Neurobiol Exp (Wars); 1993; 53(1):325-35. PubMed ID: 8317268
[TBL] [Abstract][Full Text] [Related]
25. Tau therapeutic strategies for the treatment of Alzheimer's disease.
Churcher I
Curr Top Med Chem; 2006; 6(6):579-95. PubMed ID: 16712493
[TBL] [Abstract][Full Text] [Related]
26. Dephosphorylation of Alzheimer paired helical filaments by protein phosphatase-2A and -2B.
Wang JZ; Gong CX; Zaidi T; Grundke-Iqbal I; Iqbal K
J Biol Chem; 1995 Mar; 270(9):4854-60. PubMed ID: 7876258
[TBL] [Abstract][Full Text] [Related]
27. Glycogen synthase kinase-3 is associated with neuronal and glial hyperphosphorylated tau deposits in Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration.
Ferrer I; Barrachina M; Puig B
Acta Neuropathol; 2002 Dec; 104(6):583-91. PubMed ID: 12410379
[TBL] [Abstract][Full Text] [Related]
28. Abnormal hyperphosphorylation of tau: sites, regulation, and molecular mechanism of neurofibrillary degeneration.
Wang JZ; Xia YY; Grundke-Iqbal I; Iqbal K
J Alzheimers Dis; 2013; 33 Suppl 1():S123-39. PubMed ID: 22710920
[TBL] [Abstract][Full Text] [Related]
29. Regulation of phosphorylation of tau by protein kinases in rat brain.
Sengupta A; Grundke-Iqbal I; Iqbal K
Neurochem Res; 2006 Dec; 31(12):1473-80. PubMed ID: 17120162
[TBL] [Abstract][Full Text] [Related]
30. Involvement of aberrant glycosylation in phosphorylation of tau by cdk5 and GSK-3beta.
Liu F; Iqbal K; Grundke-Iqbal I; Gong CX
FEBS Lett; 2002 Oct; 530(1-3):209-14. PubMed ID: 12387894
[TBL] [Abstract][Full Text] [Related]
31. Dephosphorylation of abnormal sites of tau factor by protein phosphatases and its implication for Alzheimer's disease.
Ono T; Yamamoto H; Tashima K; Nakashima H; Okumura E; Yamada K; Hisanaga S; Kishimoto T; Miyakawa T; Miyamoto E
Neurochem Int; 1995 Mar; 26(3):205-15. PubMed ID: 7787767
[TBL] [Abstract][Full Text] [Related]
32. Discoveries of tau, abnormally hyperphosphorylated tau and others of neurofibrillary degeneration: a personal historical perspective.
Iqbal K; Grundke-Iqbal I
J Alzheimers Dis; 2006; 9(3 Suppl):219-42. PubMed ID: 16914861
[TBL] [Abstract][Full Text] [Related]
33. B vitamin deficiency promotes tau phosphorylation through regulation of GSK3beta and PP2A.
Nicolia V; Fuso A; Cavallaro RA; Di Luzio A; Scarpa S
J Alzheimers Dis; 2010; 19(3):895-907. PubMed ID: 20157245
[TBL] [Abstract][Full Text] [Related]
34. Tau is phosphorylated by GSK-3 at several sites found in Alzheimer disease and its biological activity markedly inhibited only after it is prephosphorylated by A-kinase.
Wang JZ; Wu Q; Smith A; Grundke-Iqbal I; Iqbal K
FEBS Lett; 1998 Sep; 436(1):28-34. PubMed ID: 9771888
[TBL] [Abstract][Full Text] [Related]
35. Tau in Alzheimer disease and related tauopathies.
Iqbal K; Liu F; Gong CX; Grundke-Iqbal I
Curr Alzheimer Res; 2010 Dec; 7(8):656-64. PubMed ID: 20678074
[TBL] [Abstract][Full Text] [Related]
36. Neurofibrillary degeneration in Alzheimer's disease: from molecular mechanisms to identification of drug targets.
Pei JJ; Sjögren M; Winblad B
Curr Opin Psychiatry; 2008 Nov; 21(6):555-61. PubMed ID: 18852562
[TBL] [Abstract][Full Text] [Related]
37. Phosphorylation of human tau protein by microtubule-associated kinases: GSK3beta and cdk5 are key participants.
Flaherty DB; Soria JP; Tomasiewicz HG; Wood JG
J Neurosci Res; 2000 Nov; 62(3):463-72. PubMed ID: 11054815
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of protein phosphatase-2B (calcineurin) activity towards Alzheimer abnormally phosphorylated tau by neuroleptics.
Gong CX; Shaikh S; Grundke-Iqbal I; Iqbal K
Brain Res; 1996 Nov; 741(1-2):95-102. PubMed ID: 9001710
[TBL] [Abstract][Full Text] [Related]
39. Ginsenoside Rd attenuates beta-amyloid-induced tau phosphorylation by altering the functional balance of glycogen synthase kinase 3beta and protein phosphatase 2A.
Li L; Liu Z; Liu J; Tai X; Hu X; Liu X; Wu Z; Zhang G; Shi M; Zhao G
Neurobiol Dis; 2013 Jun; 54():320-8. PubMed ID: 23321003
[TBL] [Abstract][Full Text] [Related]
40. Phosphorylation of tau at both Thr 231 and Ser 262 is required for maximal inhibition of its binding to microtubules.
Sengupta A; Kabat J; Novak M; Wu Q; Grundke-Iqbal I; Iqbal K
Arch Biochem Biophys; 1998 Sep; 357(2):299-309. PubMed ID: 9735171
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
